Cargando…
Downregulation of lncRNA CCDC26 contributes to imatinib resistance in human gastrointestinal stromal tumors through IGF-1R upregulation
Imatinib is the first line of therapy for patients with metastatic or gastrointestinal stromal tumors (GIST). However, drug resistance limits the long-term effect of imatinib. Long non-coding RNAs (lncRNAs) are emerging as key players in regulating drug resistance in cancer. In this study, we invest...
Autores principales: | Yan, Jingyi, Chen, Didi, Chen, Xiaolei, Sun, Xuecheng, Dong, Qiantong, Hu, Changyuan, Zhou, Feng, Chen, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Associação Brasileira de Divulgação Científica
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6556970/ https://www.ncbi.nlm.nih.gov/pubmed/31166382 http://dx.doi.org/10.1590/1414-431X20198399 |
Ejemplares similares
-
Identification of imatinib-resistant long non-coding RNAs in gastrointestinal stromal tumors
por: Yan, Jingyi, et al.
Publicado: (2019) -
lncRNA-CCDC26, as a novel biomarker, predicts prognosis in acute myeloid leukemia
por: Chen, Cunte, et al.
Publicado: (2019) -
Silencing of lncRNA CCDC26 Restrains the Growth and Migration of Glioma Cells In Vitro and In Vivo via Targeting miR-203
por: Wang, Shilei, et al.
Publicado: (2018) -
Quercetin Arrests in G2 phase, Upregulates INXS LncRNA and Downregulates UCA1 LncRNA in MCF-7 Cells
por: Rezaie, Fatemeh, et al.
Publicado: (2021) -
lncRNA LINC-PINT is downregulated in melanoma and regulates cell proliferation by downregulating lncRNA BANCR
por: Huang, Qing, et al.
Publicado: (2019)